Actively Recruiting

Phase Not Applicable
Age: 40Years - 85Years
All Genders
NCT06630702

Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease

Led by National Taiwan University Hospital · Updated on 2025-11-20

5

Participants Needed

1

Research Sites

171 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Spinal cord stimulation (SCS) has proven to be effective for pain that is unresponsive to medication. This technique involves an anesthesiologist or a neurosurgeon placing stimulation electrodes at the thoracic vertebrae to provide pain relief. Although SCS is not currently a standard treatment for patients with Parkinson's disease, recent studies have shown that Parkinson's patients who experience intolerable pain and undergo SCS treatment not only experience pain relief but also show improvements in gait and other Parkinson's symptoms. Therefore, the investigators aim to use temporary, minimally invasive SCS electrodes to help patients with nrFOG (non-responsive Freezing of Gait) improve their stability and reduce their risk of falls.

CONDITIONS

Official Title

Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease

Who Can Participate

Age: 40Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 40 and 85 years old
  • Diagnosed with primary Parkinson's disease by a movement disorder specialist for more than 5 years
  • Has freezing of gait not controlled by medication
  • May have lower limb pain with or without Parkinson's non-motor symptoms
  • No other secondary gait problems
Not Eligible

You will not qualify if you...

  • Diagnosed with atypical Parkinson's disease
  • Has spinal cord injuries
  • Freezing of gait controlled by medication
  • Presence of lesions near implantation area causing spinal canal stenosis or myelopathy
  • Previous surgery or infection near implantation area that may affect implantation
  • Abnormal blood clotting or cannot stop antithrombotic drugs shortly
  • Clinical Dementia Rating Scale greater than or equal to 2.8
  • Allergy to developer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital Hsin-Chu Branch

Hsinchu, Hsinchu City, Taiwan, 300

Actively Recruiting

Loading map...

Research Team

K

Kai-Hsiang Chen, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here